From: ZnT3 mRNA levels are reduced in Alzheimer's disease post-mortem brain
Diagnosis | Gender | Age | Braak stage | pm delay (min) | CSF pH | Brain weight (g) |
---|---|---|---|---|---|---|
control | F | 69 | 1 | 375 | 6.59 | 1264 |
control | F | 72 | 1 | 405 | 6.52 | 1296 |
control | M | 79 | 1 | 320 | 6.72 | 1322 |
control | M | 83 | 1 | 275 | 6.49 | 1422 |
control | F | 88 | 2 | 340 | n.d. | 1152 |
Control mean | 3F/2 M | 78.2 | 1.2 | 343 | 6.58 | 1291 |
AD | F | 84 | 4 | 230 | 6.64 | 1196 |
AD | F | 85 | 4 | 220 | 6.59 | 1065 |
AD | F | 93 | 4 | 335 | 6.65 | 1194 |
AD | F | 84 | 4 | 230 | 6.64 | 1196 |
AD | F | 87 | 4 | 240 | 6.91 | 955 |
AD | F | 101 | 4 | 265 | 6.93 | 1016 |
AD | M | 91 | 4 | 250 | n.d. | 1160 |
AD/LBV | F | 81 | 4 | 193 | 6.54 | 1096 |
AD/LBV | F | 76 | 4 | 295 | 6.78 | 1180 |
AD | M | 67 | 5 | 260 | 6.62 | 1094 |
AD | F | 77 | 5 | 252 | 6.43 | 1151 |
AD | F | 77 | 5 | 215 | 6.67 | 1235 |
AD | M | 86 | 5 | 335 | 6.39 | 1315 |
AD | M | 95 | 5 | 185 | 6.4 | 1203 |
AD | M | 70 | 5 | 525 | 6.25 | 1220 |
AD/LBV | M | 80 | 5 | 1670 | 6.19 | 1170 |
AD/LBV | F | 69 | 5 | 295 | 6.59 | 1039 |
AD/LBV | F | 84 | 5 | 365 | 6.1 | 1116 |
AD/LBV | F | 87 | 5 | 260 | 6.17 | 1022 |
AD/LBV | M | 84 | 5 | 275 | 6.54 | 1373 |
AD | M | 58 | 6 | 385 | 6.42 | 1273 |
AD | F | 87 | 6 | 300 | 6.66 | 852 |
AD | F | 87 | 6 | 250 | 6.9 | 1047 |
AD | F | 77 | 6 | 285 | 6.74 | 1116 |
AD | F | 91 | 6 | 275 | 6.55 | 949 |
AD | F | 66 | 6 | 215 | 6.42 | 1105 |
AD/LBV | M | 54 | 6 | 610 | 6.51 | 1334 |
AD/LBV | F | 69 | 6 | 295 | 6.41 | 1003 |
AD mean | 19 F/9 M | 80.3 | 5 | 340 | 6.54 | 1131 |